|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Facial Neuralgia | |||||
| Pain | |||||
| Trigeminal Neuralgia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neuralgia | |||||
| 3 | More general conditions related to this trial | ||||
| Cranial Nerve Diseases | |||||
| Facial Nerve Diseases | |||||
| Mouth Diseases | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Neuromuscular Diseases | |||||
| Peripheral Nervous System Diseases | |||||
| Signs and Symptoms | |||||
| Stomatognathic Diseases | |||||
| Trigeminal Nerve Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Dextromethorphan | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antitussive Agents | |||||
| Central Nervous System Agents | |||||
| Excitatory Amino Acid Agents | |||||
| Excitatory Amino Acid Antagonists | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Dental and Craniofacial Research (NIDCR) | |||||